China’s contribution to gut microbiota research
Article Sidebar
Main Article Content
Abstract
Gut microbiota research is a hot topic. With the advancement of high throughput sequencing technology, gut microbiota provides a sally port for the pathogenesis of diseases, the mechanism of drug action and the strategy of treatment selection. The transformation potential of gut microbiota research is gradually being valued. This paper focuses on the study of gut microbiota, highlights the contribution of China and puts forward some views in this field.
Downloads
Article Details
Copyright (c) 2020 Wang H, et al.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Valdes AM, Walter J, Segal E, Spector TD (2018) Role of the gut microbiota in nutrition and health. BMJ 361: k2179. Link: https://bit.ly/2VPD7lI
Hill CJ, Lynch DB, Murphy K, Ulaszewska M, Jeffery IB, et al. (2017) Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort. Microbiome 5: 4. Link: https://bit.ly/3br7Ig3
Lynch SV, Pedersen O (2016) The Human Intestinal Microbiome in Health and Disease. N Engl J Med 375: 2369-2379. Link: https://bit.ly/2VJpBQJ
Zhang F, Luo W, Shi Y, Fan Z, Ji G (2012) Should we standardize the 1,700-year-old fecal microbiota transplantation?. Am J Gastroenterol 107: 1755-1756. Link: https://bit.ly/2VqDV1F
Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, et al. (2018) Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 359: 1156-1161. Link: https://bit.ly/2yufPKf
Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, et al. (2019) Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease. Neuron 103: 627-641.e7. Link: https://bit.ly/2ziDca8
Kaelberer MM, Buchanan KL, Klein ME, Barth BB, Montoya MM, et al. (2018) A gut-brain neural circuit for nutrient sensory transduction. Science 361: eaat5236. Link: https://bit.ly/2VKRnfF
Kang Y, Cai Y (2018) Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies. Clin Res Hepatol Gastroenterol 42: 110-117. Link: https://bit.ly/3br6PnJ
Ni J, Wu GD, Albenberg L, Tomov VT (2017) Gut microbiota and IBD: causation or correlation?.Nat Rev Gastroenterol Hepatol 14: 573-584. Link: https://bit.ly/2VJdu65
Tang R, Wei Y, Li Y, Chen W, Chen H, et al. (2018) Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy. Gut 67: 534-541. Link: https://bit.ly/2zamv0n
Sharon G, Cruz NJ, Kang DW, Gandal MJ, Wang B, et al. (2019) Human Gut Microbiota from Autism Spectrum Disorder Promote Behavioral Symptoms in Mice. Cell 177: 1600-1618.e17. Link: https://bit.ly/2Vqshnk
Liu P, Wu L, Peng G, Han Y, Tang R, et al. (2019) Altered microbiomes distinguish Alzheimer's disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain Behav Immun 80: 633-643. Link: https://bit.ly/2RVK9nT
Meijers B, Evenepoel P, Anders HJ (2019) Intestinal microbiome and fitness in kidney disease. Nat Rev Nephrol 15: 531-545. Link: https://bit.ly/3cyzXcN
Hidalgo-Cantabrana C, Gómez J, Delgado S, Requena-López S, Queiro-Silva R, et al. (2019) Gut microbiota dysbiosis in a cohort of patients with psoriasis. Br J Dermatol 181: 1287-1295. Link: https://bit.ly/2zam8mv
Zhao L (2013) The gut microbiota and obesity: from correlation to causality. Nat Rev Microbiol 11: 639-647. Link: https://bit.ly/2yy3rZC
Vatanen T, Franzosa EA, Schwager R, Tripathi S, Arthur TD, et al. (2018) The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature 562: 589-594. Link: https://bit.ly/2ytKsiY
Barrington WT, Lusis AJ (2017) Atherosclerosis: Association between the gut microbiome and atherosclerosis. Nat Rev Cardiol 14: 699-700. Link: https://bit.ly/2VnsVSE
Ren Z, Li A, Jiang J, Zhou L, Zujiang Y, et al. (2019) Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut 68: 1014-1023. Link: https://bit.ly/3cBQsFe
Wei Y, Li Y, Yan L, Sun C, Miao Q, et al. (2020) Alterations of gut microbiome in autoimmune hepatitis. Gut 69: 569-577. Link: https://bit.ly/2xLI3Ae
Yu T, Guo F, Yu Y, Sun T, Ma D, et al. (2017) Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell 170: 548-563.e16. Link: https://bit.ly/3aruRxM
Tsoi H, Chu ESH, Zhang X, Sheng J, Nakatsu G, et al. (2017) Peptostreptococcus anaerobius Induces Intracellular Cholesterol Biosynthesis in Colon Cells to Induce Proliferation and Causes Dysplasia in Mice. Gastroenterology 152: 1419-1433.e5. Link: https://bit.ly/2Kl3r23
Wang H, Cui B, Li Q, Ding X, Li P, et al. (2018) The Safety of Fecal Microbiota Transplantation for Crohn's Disease: Findings from A Long-Term Study. Adv Ther 35: 1935-1944. Link: https://bit.ly/2VNwpfY
Ding X, Li Q, Li P, Zhang T, Cui B, et al. (2019) Long-Term Safety and Efficacy of Fecal Microbiota Transplant in Active Ulcerative Colitis. Drug Saf 42: 869-880. Link: https://bit.ly/2Vr9mJ7
Ren YD, Ye ZS, Yang LZ, Jin LX, Wei WJ, et al. (2017) Fecal microbiota transplantation induces hepatitis B virus e-antigen (HBeAg) clearance in patients with positive HBeAg after long-term antiviral therapy. Hepatology 65: 1765-1768. Link: https://bit.ly/2VKfs6h
Xue LJ, Tong Q, Wang HG, et al. (2018) One case of Parkinson's disease treated with fecal bacteria transplantation [In Chinese]. Chin J Neuromed 17: 953-954.
D'Haens GR, Jobin C (2019) Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection. Gastroenterology 157: 624-636. Link: https://bit.ly/2VOhBhp
Allegretti JR, Mullish BH, Kelly C, Fischer M (2019) The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications. Lancet 394: 420-431. Link: https://bit.ly/2VsZC1b
Olesen SW, Panchal P, Chen J, Budree S, Osman M (2020) Global disparities in faecal microbiota transplantation research. Lancet Gastroenterol Hepatol 5: 241. Link: https://bit.ly/2zgbI4R
Depommier C, Everard A, Druart C, Plovier H, Van Hul M, et al. (2019) Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med 25: 1096-1103. Link: https://bit.ly/2VJsW2i
Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT et al. (2018) Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359: 91-97. Link: https://bit.ly/2xCVDpH
Wang L, Tang L, Feng Y, Zhao S, Han M, et al. (2020) A purified membrane protein from Akkermansia muciniphila or the pasteurised bacterium blunts colitis associated tumourigenesis by modulation of CD8+ T cells in mice. Gut. Link: https://bit.ly/2xLflPV
Rahfeld P, Sim L, Moon H, Constantinescu I, Morgan-Lang C, et al. (2019) An enzymatic pathway in the human gut microbiome that converts A to universal O type blood. Nat Microbiol 4: 1475-1485. Link: https://bit.ly/3eNFWg2
Zhang F, Cui B, He X, Nie Y, Wu K, et al. (2018) Microbiota transplantation: concept, methodology and strategy for its modernization. Protein Cell 9: 462-473. Link: https://bit.ly/2VpVSNV
Zhang T, Lu G, Zhao Z, Liu Y, Shen Q, et al. (2020) Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening. Protein Cell 11: 251-266. Link: https://bit.ly/2Ko3KsW
Wu TR, Lin CS, Chang CJ, Lin TL, Martel J, et al. (2019) Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut 68: 248-262. Link: https://bit.ly/34Wwz95
Chang CJ, Lin CS, Lu CC, Martel J, Ko YF, et al. (2015) Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun 6: 7489. Link: https://bit.ly/3brcjis
Li D, Gao C, Zhang F, Yang R, Lan C, et al. (2020) Seven facts and five initiatives for gut microbiome research. Protein Cell. Link: https://bit.ly/2xLBzkS